Review article · 25 Sep 2011
Conference abstract
Filovirus vaccines
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
E bola virus (EBOV) and Marburg virus (MARV) are members of the Filoviridae, a family of viruses classified as ?Category A? bioterrorism agents that cause severe hemorrhagic fever in humans and nonhuman primates with high morbidity and mortality rates up to 90%. After a short incubation period of 4 to 10 days, Filovirus-infected individuals develop an abrupt onset of symptoms that include fever, chills, malaise, and myalgia that are common to many other viral infections. MARV is antigenically stable and exists in only one species, whereas EBOV is more variable and has five species. Filoviruses pose a significant threat to the Public Health and National Security. There are currently no licensed vaccines or therapeutics that could be used in the event of an outbreak or release of these deadly viruses. The Filovirus glycoprotein (GP) forms spikes at the virus surface and is used for cell entry. GP induces cell mediated immunity, is the target for neutralizing antibodies, and is sufficient to elicit protective immunity against Filovirus lethal challenge in small animal and non-human primates. Several Filovirus vaccine candidates are currently under development. GP vaccines based on viral vectors, virus-like particles, and soluble proteins have shown promising results. In my presentation, I will review the state-of-the-art in Filovirus vaccine development.
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract
Regulatory considerations related to the development of filovirus vaccines
Editorial · 2020
Conference Announcement: 3rd European Congress on Vaccines RandD and Vaccination
Other · 2019
Conference Announcement: 3rd European Congress on Vaccines RandD and Vaccination
Conference proceeding · 2019
Past Conference Report on European Vaccines Congress
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advancing Immune-Based Disease Management through Therapeutic Vaccines
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Gerardo Kaplan”
